Thesissignificance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma
Thesissignificance of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and patients with hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisAngiogenic factors mediated plasminogen activators in patients with chronic liver diseases and hepatocellular carcinoma
ThesisEvaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma
ThesisEvaluation of annexin II and follistatin as potential serum markers for hepatocellular carcinoma
ThesisSignificance of serum chromogranin-A in patients withliver cirrhosis and hepatocellular carcinoma
ThesisSignificance of serum chromogranin-A in patients withliver cirrhosis and hepatocellular carcinoma